These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 14762632

  • 21. Performance of a cytomegalovirus IgG enzyme immunoassay kit modified to measure avidity.
    Prince HE, Lapé-Nixon M, Novak-Weekley SM.
    Clin Vaccine Immunol; 2014 Jun; 21(6):808-12. PubMed ID: 24671557
    [Abstract] [Full Text] [Related]

  • 22. Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen.
    Xi H, Jinjie L, Shengxiang G, Tingdong L, Han W, Xiaoyi G, Tong-Ming F, Jun Z.
    J Virol Methods; 2017 Feb; 240():21-25. PubMed ID: 27825854
    [Abstract] [Full Text] [Related]

  • 23. Maternal immunoglobulin G avidity as a diagnostic tool to identify pregnant women at risk of congenital cytomegalovirus infection.
    Kaneko M, Ohhashi M, Minematsu T, Muraoka J, Kusumoto K, Sameshima H.
    J Infect Chemother; 2017 Mar; 23(3):173-176. PubMed ID: 28034524
    [Abstract] [Full Text] [Related]

  • 24. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity.
    Dollard SC, Staras SA, Amin MM, Schmid DS, Cannon MJ.
    Clin Vaccine Immunol; 2011 Nov; 18(11):1895-9. PubMed ID: 21918114
    [Abstract] [Full Text] [Related]

  • 25. Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots.
    Rajasekariah H, Scott G, Robertson PW, Rawlinson WD.
    J Med Virol; 2013 Feb; 85(2):315-9. PubMed ID: 23171986
    [Abstract] [Full Text] [Related]

  • 26. Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus.
    Furione M, Rognoni V, Sarasini A, Zavattoni M, Lilleri D, Gerna G, Revello MG.
    J Med Virol; 2013 Nov; 85(11):1960-7. PubMed ID: 23893782
    [Abstract] [Full Text] [Related]

  • 27. Maturation of antibody avidity after primary human cytomegalovirus infection is delayed in immunosuppressed solid organ transplant patients.
    Lutz E, Ward KN, Gray JJ.
    J Med Virol; 1994 Dec; 44(4):317-22. PubMed ID: 7897362
    [Abstract] [Full Text] [Related]

  • 28. Pattern of the epitope-specific IgG/IgM response against human cytomegalovirus in patients with multiple myeloma.
    Bogner E, Pecher G.
    Clin Vaccine Immunol; 2013 Aug; 20(8):1298-304. PubMed ID: 23784854
    [Abstract] [Full Text] [Related]

  • 29. Ability of three IgG-avidity assays to exclude recent cytomegalovirus infection.
    Bodéus M, Beulné D, Goubau P.
    Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):248-52. PubMed ID: 11399014
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Positive predictive value of anti-HCMV IgM as an index of primary infection.
    De Paschale M, Agrappi C, Manco MT, Clerici P.
    J Virol Methods; 2010 Sep; 168(1-2):121-5. PubMed ID: 20470827
    [Abstract] [Full Text] [Related]

  • 32. The combination of specific IgM antibodies and IgG antibodies of low avidity does not always indicate primary infection with cytomegalovirus.
    Lumley S, Patel M, Griffiths PD.
    J Med Virol; 2014 May; 86(5):834-7. PubMed ID: 24395084
    [Abstract] [Full Text] [Related]

  • 33. [Performance of the IgG avidity test in patients with cytomegalovirus disease].
    Lafarga B, Noguera FJ, Bolanos M, Pérez MC, Rodríguez H.
    Enferm Infecc Microbiol Clin; 1997 Apr; 15(4):190-5. PubMed ID: 9312277
    [Abstract] [Full Text] [Related]

  • 34. Clinical evaluation of a chemiluminescence immunoassay for determination of immunoglobulin g avidity to human cytomegalovirus.
    Revello MG, Gorini G, Gerna G.
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):801-5. PubMed ID: 15242963
    [Abstract] [Full Text] [Related]

  • 35. [Enzyme immunoassay system for the detection of low-avid lgG antibodies to human cytomegalovirus ("CMV-diagnost")].
    Ebralidze LK, Vedunova SL, Mal'tseva NN, Lavrov VF, Gol'tsov VA, Zverev VV.
    Vopr Virusol; 2005 Jul; 50(6):41-4. PubMed ID: 16408631
    [Abstract] [Full Text] [Related]

  • 36. [The use of IgG antibody avidity assays in the diagnosis of cytomegalovirus infection].
    Stepánová V, Plísková L, Kubisová M, Stepánová E, Bolehovská R, Bostíková V, Svobodová M.
    Epidemiol Mikrobiol Imunol; 2011 Sep; 60(3):115-20. PubMed ID: 22132653
    [Abstract] [Full Text] [Related]

  • 37. Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays.
    Curdt I, Praast G, Sickinger E, Schultess J, Herold I, Braun HB, Bernhardt S, Maine GT, Smith DD, Hsu S, Christ HM, Pucci D, Hausmann M, Herzogenrath J.
    J Clin Microbiol; 2009 Mar; 47(3):603-13. PubMed ID: 19129411
    [Abstract] [Full Text] [Related]

  • 38. A simple, rapid enzyme-linked immunosorbent assay for evaluating immunoglobin G antibody avidity in toxoplasmosis.
    Rossi CL.
    Diagn Microbiol Infect Dis; 1998 Jan; 30(1):25-30. PubMed ID: 9488827
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Relationship of IgG avidity index and IgM levels for the differential diagnosis of primary from recurrent cytomegalovirus infections.
    Chakravarti A, Kashyap B, Wadhwa A.
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):197-201. PubMed ID: 18094442
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.